161 related articles for article (PubMed ID: 11733074)
41. Measurement of HPRT mutations in splenic lymphocytes and haemoglobin adducts in erythrocytes of Lewis rats exposed to ethylene oxide.
Tates AD; van Dam FJ; Natarajan AT; van Teylingen CM; de Zwart FA; Zwinderman AH; van Sittert NJ; Nilsen A; Nilsen OG; Zahlsen K; Magnusson AL; Törnqvist M
Mutat Res; 1999 Dec; 431(2):397-415. PubMed ID: 10636004
[TBL] [Abstract][Full Text] [Related]
42. Mutational specificity of glyoxal, a product of DNA oxidation, in the lacI gene of wild-type Escherichia coli W3110.
Murata-Kamiya N; Kamiya H; Kaji H; Kasai H
Mutat Res; 1997 Jul; 377(2):255-62. PubMed ID: 9247622
[TBL] [Abstract][Full Text] [Related]
43. In vivo mutagenicity of ethylene oxide at the hprt locus in T-lymphocytes of B6C3F1 lacI transgenic mice following inhalation exposure.
Walker VE; Sisk SC; Upton PB; Wong BA; Recio L
Mutat Res; 1997 Aug; 392(3):211-22. PubMed ID: 9294020
[TBL] [Abstract][Full Text] [Related]
44. Oxazepam is mutagenic in vivo in Big Blue transgenic mice.
Shane BS; deBoer JG; Glickman BW; Cunningham ML
Carcinogenesis; 1999 Jul; 20(7):1315-21. PubMed ID: 10383906
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of lacI mutation in germ cells and micronuclei in peripheral blood after treatment of male lacI transgenic mice with ethylnitrosourea, isopropylmethane sulfonate or methylmethane sulfonate.
Gorelick NJ; Andrews JL; Gibson DP; Carr GJ; Aardema MJ
Mutat Res; 1997 Feb; 388(2-3):187-95. PubMed ID: 9057880
[TBL] [Abstract][Full Text] [Related]
46. N-(2-chloroethyl)-N-nitrosourea tethered to lexitropsin induces minor groove lesions at the p53 cDNA that are more cytotoxic than mutagenic.
Inga A; Chen FX; Monti P; Aprile A; Campomenosi P; Menichini P; Ottaggio L; Viaggi S; Abbondandolo A; Gold B; Fronza G
Cancer Res; 1999 Feb; 59(3):689-95. PubMed ID: 9973219
[TBL] [Abstract][Full Text] [Related]
47. Aflatoxin B1 induced lacI mutation in liver and kidney of transgenic mice C57BL/6N: effect of phorone.
Autrup H; Jørgensen EC; Jensen O
Mutagenesis; 1996 Jan; 11(1):69-73. PubMed ID: 8671718
[TBL] [Abstract][Full Text] [Related]
48. Mutations induced by alpha-hydroxytamoxifen in the lacI and cII genes of Big Blue transgenic rats.
Chen T; Gamboa da Costa G; Marques MM; Shelton SD; Beland FA; Manjanatha MG
Carcinogenesis; 2002 Oct; 23(10):1751-7. PubMed ID: 12376486
[TBL] [Abstract][Full Text] [Related]
49. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene.
Hayward JJ; Shane BS; Tindall KR; Cunningham ML
Carcinogenesis; 1995 Oct; 16(10):2429-33. PubMed ID: 7586147
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of spontaneous and chemical-induced lacI mutations in germ cells from lambda/lacI transgenic mice.
Putman DL; Ritter AP; Carr GJ; Young RR
Mutat Res; 1997 Feb; 388(2-3):137-43. PubMed ID: 9057874
[TBL] [Abstract][Full Text] [Related]
51. Tissue-specific mutant frequencies and mutational spectra in cyclophosphamide-treated lacI transgenic mice.
Gorelick NJ; Andrews JL; deBoer JG; Young R; Gibson DP; Walker VE
Environ Mol Mutagen; 1999; 34(2-3):154-66. PubMed ID: 10529740
[TBL] [Abstract][Full Text] [Related]
52. DNA adducts, mutant frequencies, and mutation spectra in various organs of lambda lacZ mice exposed to ethylating agents.
Mientjes EJ; Luiten-Schuite A; van der Wolf E; Borsboom Y; Bergmans A; Berends F; Lohman PH; Baan RA; van Delft JH
Environ Mol Mutagen; 1998; 31(1):18-31. PubMed ID: 9464312
[TBL] [Abstract][Full Text] [Related]
53. Lung-specific mutagenicity and mutational spectrum in B6C3F1 lacI transgenic mice following inhalation exposure to 1,2-epoxybutene.
Saranko CJ; Meyer KG; Pluta LJ; Henderson RF; Recio L
Mutat Res; 2001 Jan; 473(1):37-49. PubMed ID: 11166025
[TBL] [Abstract][Full Text] [Related]
54. Preferential alkylation by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) of guanines with guanines as neighboring bases in DNA.
Briscoe WT; Duarte SP
Biochem Pharmacol; 1988 Mar; 37(6):1061-6. PubMed ID: 3355582
[TBL] [Abstract][Full Text] [Related]
55. Spontaneous mutations in the Big Blue transgenic system are primarily mouse derived.
Hill KA; Buettner VL; Glickman BW; Sommer SS
Mutat Res; 1999 Jan; 436(1):11-9. PubMed ID: 9878678
[TBL] [Abstract][Full Text] [Related]
56. Mutations induced in male germ cells after treatment of transgenic mice with ethylnitrosourea.
Katoh M; Horiya N; Valdivia RP
Mutat Res; 1997 Feb; 388(2-3):229-37. PubMed ID: 9057885
[TBL] [Abstract][Full Text] [Related]
57. The in vivo mutagenicity and mutational spectrum at the lacI transgene recovered from the spleens of B6C3F1 lacI transgenic mice following a 4-week inhalation exposure to 1,3-butadiene.
Recio L; Pluta LJ; Meyer KG
Mutat Res; 1998 Jun; 401(1-2):99-110. PubMed ID: 9639685
[TBL] [Abstract][Full Text] [Related]
58. DNA repair: counteragent in mutagenesis and carcinogenesis-- accomplice in cancer therapy resistance.
Rajewsky MF; Engelbergs J; Thomale J; Schweer T
Mutat Res; 2000 Apr; 462(2-3):101-5. PubMed ID: 10767621
[TBL] [Abstract][Full Text] [Related]
59. DNA adduct level induced by 2-amino-3,4-dimethylimidazo[4,5-f]-quinoline in Big Blue mice does not correlate with mutagenicity.
Ochiai M; Ishida K; Ushijima T; Suzuki T; Sofuni T; Sugimura T; Nagao M
Mutagenesis; 1998 Jul; 13(4):381-4. PubMed ID: 9717175
[TBL] [Abstract][Full Text] [Related]
60. Chemical synthesis and detection of the cross-link 1-[N3-(2'-deoxycytidyl)]-2-[N1-(2'-deoxyguanosinyl)]ethane in DNA reacted with 1-(2-chloroethyl)-1-nitrosourea.
Bodell WJ; Pongracz K
Chem Res Toxicol; 1993; 6(4):434-8. PubMed ID: 8374039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
